Praxis Precision Medicines Announces Plans to File an NDA for Relutrigine in SCN2A and SCN8A Developmental and Epileptic Encephalopathies in Early 2026

Detailed price information for Praxis Precision Medicines Inc (PRAX-Q) from The Globe and Mail including charting and trades.

Praxis Precision Medicines Announces Alignment with FDA on Simplified and Accelerated Registrational Pathway for Elsunersen in Early Onset SCN2A Developmental and Epileptic ...

Detailed price information for Praxis Precision Medicines Inc (PRAX-Q) from The Globe and Mail including charting and trades.

Game No. 30 Preview: Flyers vs. Hurricanes

The Philadelphia Flyers are in South Philly for the last game of their current homestand on Saturday night with another ...

Guinness world record set in Beamsville

Youngsters at St. John Catholic Elementary School and the YMCA child care centre in Beamsville lay claim to having created ...